Sarah Gheuens - Chief Medical Officer at AGIOS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
AGIO on Nasdaq
All Insider Reports
All Insider Reports

Sarah Gheuens - trading volume in the past year for AGIOS PHARMACEUTICALS, INC.

Holdings reported by Sarah Gheuens for AGIOS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 74,406 $2,154,797 $28.96 02 Mar 2026 Direct
Restricted stock units 8,000 $402,775 $35.54 02 Mar 2026 Direct Common stock
Stock options (right to buy) 52,000 01 Mar 2026 Direct Common stock
Performance share units 0 30 Dec 2025 Direct Common stock

Transactions reported by Sarah Gheuens for AGIOS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.